"CORONAVIRUS INFO: Penn Medicine is dedicated to the health and safety of patients, their families, and our staff. Please visit our website for COVID-19 updates, including coronavirus FAQs, our visitation policy, and drive-thru testing."

During the past decade, Hospital of the University of Pennsylvania (Penn Heart and Vascular Center) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital of the University of Pennsylvania (Penn Heart and Vascular Center)" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "Oxford University Hospitals NHS Trust" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Hospital of the University of Pennsylvania (Penn Heart and Vascular Center)" are "Cardiomyopathy, Hypertrophic Obstructive" (1 trials), "Hypertrophic Cardiomyopathy" (1 trials) and "Left Ventricular Outflow Tract Obstruction" (1 trials). Many other conditions were trialed in "Hospital of the University of Pennsylvania (Penn Heart and Vascular Center)" in a lesser frequency.

Most popular intervention types in "Hospital of the University of Pennsylvania (Penn Heart and Vascular Center)" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "MYK-461" (1 trials) and "None - this is an observational study" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital of the University of Pennsylvania (Penn Heart and Vascular Center)" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hospital of the University of Pennsylvania (Penn Heart and Vascular Center)". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hospital of the University of Pennsylvania (Penn Heart and Vascular Center), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital of the University of Pennsylvania (Penn Heart and Vascular Center), 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".